These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 24931179)

  • 21. Ablation for the treatment of Brugada syndrome: current status and future prospects.
    Rizzo A; de Asmundis C; Brugada P; La Meir M; Chierchia GB
    Expert Rev Med Devices; 2020 Feb; 17(2):123-130. PubMed ID: 31986921
    [No Abstract]   [Full Text] [Related]  

  • 22. Mapping and ablation of ventricular fibrillation associated with long-QT and Brugada syndromes.
    Haïssaguerre M; Extramiana F; Hocini M; Cauchemez B; Jaïs P; Cabrera JA; Farré J; Leenhardt A; Sanders P; Scavée C; Hsu LF; Weerasooriya R; Shah DC; Frank R; Maury P; Delay M; Garrigue S; Clémenty J
    Circulation; 2003 Aug; 108(8):925-8. PubMed ID: 12925452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes of catheter ablation in high-risk patients with Brugada syndrome refusing an implantable cardioverter defibrillator implantation.
    Li L; Ding L; Zhou L; Wu L; Zheng L; Zhang Z; Xiong Y; Zhang Z; Yao Y
    Europace; 2023 Dec; 26(1):. PubMed ID: 37889958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endocardial mapping and catheter ablation for ventricular fibrillation prevention in Brugada syndrome.
    Sunsaneewitayakul B; Yao Y; Thamaree S; Zhang S
    J Cardiovasc Electrophysiol; 2012 Nov; 23 Suppl 1():S10-6. PubMed ID: 22988965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Catheter ablation for electrical storm in Brugada syndrome: Results of substrate based ablation.
    Shelke A; Tachil A; Saggu D; Jesuraj ML; Yalagudri S; Narasimhan C
    Indian Heart J; 2018; 70(2):296-302. PubMed ID: 29716710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-risk Brugada syndrome: factors associated with arrhythmia recurrence and benefits of epicardial ablation in addition to implantable cardioverter defibrillator implantation.
    Santinelli V; Ciconte G; Manguso F; Anastasia L; Micaglio E; Calovic Z; Vicedomini G; Mazza B; Vecchi M; Mecarocci V; Locati ET; Boccellino A; Negro G; Napolano A; Giannelli L; Pappone C
    Europace; 2023 Dec; 26(1):. PubMed ID: 38252933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of low-dose quinidine on ventricular tachyarrhythmias in patients with Brugada syndrome: low-dose quinidine therapy as an adjunctive treatment.
    Mizusawa Y; Sakurada H; Nishizaki M; Hiraoka M
    J Cardiovasc Pharmacol; 2006 Mar; 47(3):359-64. PubMed ID: 16633076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quinidine for the management of electrical storm in an old patient with Brugada syndrome and syncope.
    Pellegrino PL; Di Biase M; Brunetti ND
    Acta Cardiol; 2013 Apr; 68(2):201-3. PubMed ID: 23705565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of endocardial ablation in eliminating an epicardial arrhythmogenic substrate in patients with Brugada syndrome.
    Kamakura T; Cochet H; Juhoor M; Nakatani Y; Ramirez FD; André C; Nakashima T; Krisai P; Takagi T; Tixier R; Chauvel R; Cheniti G; Duchateau J; Pambrun T; Derval N; Kusano K; Sacher F; Jaïs P; Haïssaguerre M; Hocini M
    Heart Rhythm; 2021 Oct; 18(10):1673-1681. PubMed ID: 34182174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Right ventricular epicardial arrhythmogenic substrate in long-QT syndrome patients at risk of sudden death.
    Pappone C; Ciconte G; Anastasia L; Gaita F; Grant E; Micaglio E; Locati ET; Calovic Z; Vicedomini G; Santinelli V
    Europace; 2023 Mar; 25(3):948-955. PubMed ID: 36610790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term outcomes of combined epicardial and endocardial ablation of monomorphic ventricular tachycardia related to hypertrophic cardiomyopathy.
    Dukkipati SR; d'Avila A; Soejima K; Bala R; Inada K; Singh S; Stevenson WG; Marchlinski FE; Reddy VY
    Circ Arrhythm Electrophysiol; 2011 Apr; 4(2):185-94. PubMed ID: 21270104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ablation of ventricular arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy: arrhythmia-free survival after endo-epicardial substrate based mapping and ablation.
    Bai R; Di Biase L; Shivkumar K; Mohanty P; Tung R; Santangeli P; Saenz LC; Vacca M; Verma A; Khaykin Y; Mohanty S; Burkhardt JD; Hongo R; Beheiry S; Dello Russo A; Casella M; Pelargonio G; Santarelli P; Sanchez J; Tondo C; Natale A
    Circ Arrhythm Electrophysiol; 2011 Aug; 4(4):478-85. PubMed ID: 21665983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 'Vanishing' fragmented potential at the epicardium in a patient with Brugada syndrome.
    Hayashi T; Sekiguchi Y; Yamamoto S; Fujita H
    BMJ Case Rep; 2022 Jul; 15(7):. PubMed ID: 35906039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pilsicainide-induced Brugada-type ECG and ventricular arrhythmias originating from the left posterior fascicle in a case with Brugada syndrome associated with idiopathic left ventricular tachycardia.
    Ueyama T; Shimizu A; Esato M; Yoshiga Y; Sawa A; Suzuki S; Sugi N; Matsuzaki M
    Europace; 2008 Jan; 10(1):86-90. PubMed ID: 18037690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The QUIDAM study: Hydroquinidine therapy for the management of Brugada syndrome patients at high arrhythmic risk.
    Andorin A; Gourraud JB; Mansourati J; Fouchard S; le Marec H; Maury P; Mabo P; Hermida JS; Deharo JC; Delasalle B; Esnault S; Sadoul N; Davy JM; Leenhardt A; Klug D; Defaye P; Babuty D; Sacher F; Probst V
    Heart Rhythm; 2017 Aug; 14(8):1147-1154. PubMed ID: 28411139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms Underlying Epicardial Radiofrequency Ablation to Suppress Arrhythmogenesis in Experimental Models of Brugada Syndrome.
    Patocskai B; Yoon N; Antzelevitch C
    JACC Clin Electrophysiol; 2017 Apr; 3(4):353-363. PubMed ID: 28948234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Catheter ablation in highly symptomatic Brugada patients: a Dutch case series.
    Haanschoten DM; Elvan A; Postema PG; Smit JJJ; Adiyaman A; Ter Bekke RMA; Asaad N; Aanhaanen WTJ; Misier ARR; Delnoy PPHM; Crijns HJGM; Wilde AAM
    Clin Res Cardiol; 2020 May; 109(5):560-569. PubMed ID: 31478073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiofrequency catheter ablation of idiopathic ventricular arrhythmias originating from intramural foci in the left ventricular outflow tract: efficacy of sequential versus simultaneous unipolar catheter ablation.
    Yamada T; Maddox WR; McElderry HT; Doppalapudi H; Plumb VJ; Kay GN
    Circ Arrhythm Electrophysiol; 2015 Apr; 8(2):344-52. PubMed ID: 25637597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Near fatal ventricular fibrillation in Brugada syndrome despite presence of an implanted implantable cardioverter defibrillator.
    Belhassen B; Viskin S
    Can J Cardiol; 2014 Nov; 30(11):1460.e3-5. PubMed ID: 25240706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dormant conduction in the right ventricular outflow tract unmasked by adenosine in a patient with Brugada syndrome.
    Kamakura T; Duchateau J; Sacher F; Jais P; Haïssaguerre M; Hocini M
    J Cardiovasc Electrophysiol; 2021 Apr; 32(4):1182-1186. PubMed ID: 33634535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.